With world-class state-of-the-art facilities and technology, increased capabilities: energetic chemistry, continuous flow process, controlled substances, particle engineering, high potency - with world-class potent handling capability (down to low nanogram per cubic meter levels). We have multiple cGMP manufacturing and development sites, with over ~1000 m³ of capacity among 6 sites including USA,
Korea and Ireland. Our scientists and engineers are leaders in continuous manufacturing methodologies (tubular and fixed bed reactions and CSTRs), having successfully developed processes from low kilograms through to 10s of tonnes. We are a world leader in Simulated Moving Bed technology (SMB) and offer this powerful technology from lab through pilot to large commercial scale. We have a proven track record in successfully developing processes involving highly energetic chemistry and now offer supply capability for Controlled Substances from our DEA-approved facilities in Virginia and California. In addition to providing analytical development and validation for all of the products that we manufacture in our global network, we also provide this same service for other customers as a stand-alone business at our Analytical Services facility in California
As leaders in operational excellence and continuous improvement and boast exceptional technical capabilities. The global presence of our highly skilled and experienced team offers total support from development through to commercial production including seamless project transfer and management plus flexibility in R&D and manufacturing. All our plants have been approved by global regulatory agencies including the FDA, EMEA, PDMA and Korean MFDS.
